GNFT
Price
$4.14
Change
+$0.16 (+4.02%)
Updated
Jul 25 closing price
Capitalization
208.16M
56 days until earnings call
KTTA
Price
$0.73
Change
-$0.01 (-1.35%)
Updated
Jul 25 closing price
Capitalization
5.4M
Interact to see
Advertisement

GNFT vs KTTA

Header iconGNFT vs KTTA Comparison
Open Charts GNFT vs KTTABanner chart's image
Genfit SA
Price$4.14
Change+$0.16 (+4.02%)
Volume$850
Capitalization208.16M
Pasithea Therapeutics
Price$0.73
Change-$0.01 (-1.35%)
Volume$112.11K
Capitalization5.4M
GNFT vs KTTA Comparison Chart in %
Loading...
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNFT vs. KTTA commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNFT is a StrongBuy and KTTA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (GNFT: $4.14 vs. KTTA: $0.74)
Brand notoriety: GNFT and KTTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNFT: 24% vs. KTTA: 0%
Market capitalization -- GNFT: $208.16M vs. KTTA: $5.4M
GNFT [@Biotechnology] is valued at $208.16M. KTTA’s [@Biotechnology] market capitalization is $5.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNFT’s FA Score shows that 1 FA rating(s) are green whileKTTA’s FA Score has 1 green FA rating(s).

  • GNFT’s FA Score: 1 green, 4 red.
  • KTTA’s FA Score: 1 green, 4 red.
According to our system of comparison, GNFT is a better buy in the long-term than KTTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNFT’s TA Score shows that 5 TA indicator(s) are bullish while KTTA’s TA Score has 5 bullish TA indicator(s).

  • GNFT’s TA Score: 5 bullish, 5 bearish.
  • KTTA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KTTA is a better buy in the short-term than GNFT.

Price Growth

GNFT (@Biotechnology) experienced а +9.23% price change this week, while KTTA (@Biotechnology) price change was +2.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

GNFT is expected to report earnings on Sep 22, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNFT($208M) has a higher market cap than KTTA($5.4M). GNFT YTD gains are higher at: 11.440 vs. KTTA (-76.625).
GNFTKTTAGNFT / KTTA
Capitalization208M5.4M3,849%
EBITDAN/A-13.24M-
Gain YTD11.440-76.625-15%
P/E Ratio117.22N/A-
RevenueN/A0-
Total CashN/A5.34M-
Total DebtN/A0-
FUNDAMENTALS RATINGS
GNFT: Fundamental Ratings
GNFT
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNFTKTTA
RSI
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 19 days ago
71%
Bullish Trend 4 days ago
70%
Declines
ODDS (%)
Bearish Trend 17 days ago
86%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BPIRF8.00N/A
N/A
Piraeus Financial Holdings S.A.
LKHLY12.88N/A
N/A
Lonking Holdings, Ltd.
MOJO0.50N/A
N/A
Equator Beverage Company
SDVKF24.72N/A
N/A
Sandvik AB
OMZNF0.32-0.01
-3.19%
Osisko Metals Inc.

GNFT and

Correlation & Price change

A.I.dvisor tells us that GNFT and BCDA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNFT and BCDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNFT
1D Price
Change %
GNFT100%
+3.99%
BCDA - GNFT
26%
Poorly correlated
+1.73%
QURE - GNFT
24%
Poorly correlated
-0.66%
FENC - GNFT
24%
Poorly correlated
-1.03%
GUTS - GNFT
23%
Poorly correlated
+0.52%
GLPG - GNFT
23%
Poorly correlated
+5.83%
More

KTTA and

Correlation & Price change

A.I.dvisor tells us that KTTA and INCY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and INCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
N/A
INCY - KTTA
28%
Poorly correlated
-0.41%
SCNI - KTTA
26%
Poorly correlated
-3.74%
GNFT - KTTA
22%
Poorly correlated
+3.99%
TRAW - KTTA
22%
Poorly correlated
-6.51%
SPRO - KTTA
21%
Poorly correlated
-0.85%
More